Dr. Casey Means, MD is the Co-Founder and Chief Medical Officer at Levels, a metabolic health company that provides individuals “real-time continuous glucose biofeedback coupled with machine-learning driven insights to inform personalized diet and lifestyle choices.”
Glucose, unlike other biomarkers, provides us a closed biofeedback loop which if tracked helps us make better diet and lifestyle choices on the fly. Other biomarkers, such as genetics or cholesterol, do not provide that real-time information which means we cannot track changes around them based on our nutritional and lifestyle choices on a day-to-day basis.
“The beauty of glucose,” says Dr. Means, “is that there are tools, right now, that can measure our glucose levels in real-time, at home, with a wearable sensor. Unlike these other variables, we can actually see how this biomarker is changing based on choices that we made five minutes ago.”
For several years, glucose monitors have been available as a treatment tool for diabetes. What Levels has done is take this technology to the mass consumer market to be used as a precision nutrition tool.
Listen in as Dr. Means explains how Levels translates real-time insights around your blood glucose into actionable steps that you can use to improve your metabolic health today.
Follow Dr. Casey @drcaseyskitchen
Follow Levels @levels
Follow Chase @chase_chewning
Key Highlights
Episode resources: